Patents by Inventor Francis W. Sweet

Francis W. Sweet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6889278
    Abstract: A system and technique provides fast acknowledgement and servicing of interrupt sources coupled to a high latency path of an intermediate node of a computer network. An external device coupled to the high latency path is provided with a separate interrupt signal for each type of interrupt supported by a processor of the intermediate node. Each interrupt signal is directly fed to an interrupt multiplexing device over a first low latency path. The multiplexing device is accessible to the processor through a second low latency path. The external device asserts an interrupt by “pulsing” an appropriate interrupt signal to the multiplexing device. The multiplexing device maintains a current counter for each interrupt signal and increments that counter every time an interrupt pulse is detected. In addition to the counter, the multiplexing device maintains a status bit for each interrupt.
    Type: Grant
    Filed: April 4, 2001
    Date of Patent: May 3, 2005
    Assignee: Cisco Technology, Inc.
    Inventors: Johannes Markus Hoerler, Francis W. Sweet, Jr., Joseph Turner
  • Patent number: 4073904
    Abstract: Disclosed are novel compounds and pharmaceutical formulations having antiviral activity. The disclosed compounds have the formula ##STR1## wherein one R.sup.2 is a hydrogen atom and the other R.sup.2 is the radical ##STR2## A is a straight chain alkylene group having 2 or 3 carbon atoms and each R.sup.3 and R.sup.4 is a hydrogen atom, and alkyl radical having 1 to 3 carbon atoms or each set of R.sup.3 and R.sup.4 taken together with the nitrogen atom to which they are attached is a saturated monocyclic heterocyclic group. Also included are the acid addition salts of these bases. These compounds may be prepared by various methods which are described.
    Type: Grant
    Filed: January 26, 1976
    Date of Patent: February 14, 1978
    Assignee: Richardson-Merrell, Inc.
    Inventors: Robert W. Fleming, Arthur D. Sill, Francis W. Sweet
  • Patent number: 4048230
    Abstract: Novel 3,6-bis basic ketone derivatives of acenaphthene, their preparation and use for the prevention and inhibition of viral infections are disclosed.
    Type: Grant
    Filed: December 21, 1972
    Date of Patent: September 13, 1977
    Assignee: Richardson-Merrell Inc.
    Inventors: Arthur D. Sill, Francis W. Sweet
  • Patent number: 4008240
    Abstract: Novel 2,7-bis basic alkanol derivatives of xanthene and thioxanthene, their preparation and use for the prevention and inhibition of viral infections are disclosed.
    Type: Grant
    Filed: December 21, 1972
    Date of Patent: February 15, 1977
    Assignee: Richardson-Merrell Inc.
    Inventors: Arthur D. Sill, Francis W. Sweet
  • Patent number: 3974186
    Abstract: Disclosed are novel compounds and pharmaceutical formulations having antiviral activity. The disclosed compounds have the formula ##SPC1##Wherein one R.sup.2 is a hydrogen atom and the other R.sup.2 is the radical ##SPC2##A is a straight chain alkylene group having 2 or 3 carbon atoms and each R.sup.3 and R.sup.4 is a hydrogen atom, an alkyl radical having 1 to 3 carbon atoms or each set of R.sup.3 and R.sup.4 taken together with the nitrogen atom to which they are attached is a saturated monocyclic heterocyclic group. Also included are the acid addition salts of these bases. These compounds may be prepared by various methods which are described.
    Type: Grant
    Filed: September 5, 1973
    Date of Patent: August 10, 1976
    Assignee: Richardson-Merrell Inc.
    Inventors: Robert W. Fleming, Arthur D. Sill, Francis W. Sweet
  • Patent number: 3957989
    Abstract: Novel bis-basic ketones of xanthene and xanthen-9-one have antiviral activity when administered orally and parenterally. The compounds are represented by the following formula: ##SPC1##Wherein Z is oxygen or H.sub.2 ; each A is a straight or branched alkylene chain having from 1 to about 6 carbon atoms; and each Y isA. the group ##EQU1## wherein R.sup.1 and R.sup.2 are individually hydrogen, lower alkyl having from 1 to about 6 carbon atoms, cycloalkyl having from 3 to 6 carbon atoms, alkenyl of from 3 to 6 carbon atoms and having the vinyl unsaturation in other than the 1-position of the alkenyl group; orB. the group ##EQU2## WHEREIN N IS A WHOLE INTEGER FROM 4 TO 6, AND R.sup.3 is hydrogen, lower alkyl of from 1 to about 4 carbon atoms and can be linked to any one of the carbon atoms of the heterocyclic group; orC. the group ##EQU3## wherein X is oxygen or NR.sup.4, and R.sup.4 is hydrogen or lower alkyl of from 1 to about 4 carbon atoms;Or a pharmaceutically acceptable acid addition salt thereof.
    Type: Grant
    Filed: February 20, 1973
    Date of Patent: May 18, 1976
    Assignee: Richardson-Merrell Inc.
    Inventors: Robert W. Fleming, Arthur D. Sill, Francis W. Sweet
  • Patent number: 3954983
    Abstract: Novel triazolobenzocycloalkylthiadiazines, their preparation, and use as central nervous system antidepressants.
    Type: Grant
    Filed: April 28, 1975
    Date of Patent: May 4, 1976
    Assignee: Richardson-Merrell Inc.
    Inventors: William L. Albrecht, Francis W. Sweet